Lv31
300 积分 2025-09-25 加入
Computationally designed antibody–drug conjugates self-assembled via affinity ligands
5小时前
已完结
Exploring the next generation of antibody–drug conjugates
5小时前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1个月前
已完结
Enabling Access to sp 3 ‐Enriched Targeted Protein Degraders via Redox‐Neutral Radical Cross‐Coupling
2个月前
已完结
Harnessing FBXO31 with terminal amide-functionalized molecules for targeted protein degradation
2个月前
已完结
Further Insight into the DNA Recognition Mechanism of Trabectedin from the Differential Affinity of Its Demethylated Analogue Ecteinascidin ET729 for the Triplet DNA Binding Site CGA
3个月前
已完结
The Role of Natural Product Chemistry in Drug Discovery: Two Decades of Progress and Perspectives
3个月前
已完结
Discovery of Novel Alkynylbenzene Scaffold-Based PTPN2-Selective Degrader PD-305 with Exceptional Potency and In Vivo Efficacy
3个月前
已完结
Trabectedin Mechanism of Action: What’s New?
3个月前
已关闭
Azole derivatives as histamine H3 receptor antagonists, Part I: Thiazol-2-yl ethers
3个月前
已关闭
皖公网安备34019202002308
